LSMO-01 - Lunch break symposium: Role of quality-of-life in driving superior patient outcomes in self-care (Supported by Haleon)
Meeting room 1.60
Chair(s)
Mr Sherif Guorgui, President of the FIP Community Pharmacy Section, CanadaIntroduction
A scientific forum on the importance of supporting quality of life as part of treatment goals for sufferers of the common cold and osteoarthritis using real world data as evidence.
Programme
| 13:00 – 13:05 | Chair introduction |
| 13:05 – 13:25 | Relevance of quality of life in patient care Ms Ema Paulino, Associação Nacional das Farmácias (ANF), Portugal |
| 13:25 – 14:00 |
Quality of Life in patient care : Learnings on ‘what matters’ from Big Data, RWE |
| 14:00 – 14:10 | Q&A |
| 14:10 – 14:15 | Closing |
Learning objectives
- Understand the role of impact on quality of life in patient’s experiences of illnesses.
- To identify the real-life impact of common cold and osteoarthritis on the quality of life and it’s impact on overall outcome for patients.
- To understand the role of real world data in understanding patient expectations and experiences to improve overall outcome in sufferers of common cold and osteoarthritis.
Take home messages
- Quality of life during or aftermath of any illness is an important aspect that needs to be understood and considered while determining the management options.
- Common health conditions too have equally debilitating impact on quality of life as serious illnesses.
- Nasal congestion from the common cold has a negative impact on the quality of life of sufferers with regards to sleep quality, vitality, physical activity, social activity and sensation.
- Various (Pharmacological and non-pharmacological) Strategies can be applied to alleviate quality of life during common cold.
- It’s important to understand the role of nasal decongestants in improving Qol in sufferers of common cold through examples of real-world data.
- Osteoarthritis is debilitating for sufferers and affects multiple dimensions of quality of life as the disease progresses. Latest Data on Qol impacted in OA and patient expectations from treatment will be presented.
- Role of real-world big data and role of pharmacists in understanding patient’s perspectives and experiences for better Qol in pain management will be presented.